About Symbios Medical Products
Symbios, headquartered in Indianapolis, IN, is a medical device company that designs, manufactures, markets and sells pain management solutions. Symbios' products, commonly known as disposable pain pumps, deliver anesthesia pain medication to post-surgical sites and regional nerve pain block areas. The company's products are used in orthopedic surgeries as well as an increasing number of general surgery applications. Symbios' principal technology platform was launched in 2004 when it purchased key assets and intellectual property from orthopedic manufacturer and marketer Biomet, Inc.
Missing: Symbios Medical Products's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Symbios Medical Products's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Symbios Medical Products News
Aug 19, 2013
One of the Indianapolis area’s most promising medical-device startups is dead. Symbios Medical Products LLC filed for Chapter 7 bankruptcy liquidation after a product recall soured its relationship with its main distributor.
Symbios Medical Products Frequently Asked Questions (FAQ)
When was Symbios Medical Products founded?
Symbios Medical Products was founded in 2003.
Where is Symbios Medical Products's headquarters?
Symbios Medical Products's headquarters is located at 7301 Georgetown Road, Indianapolis.
What is Symbios Medical Products's latest funding round?
Symbios Medical Products's latest funding round is Dead.
How much did Symbios Medical Products raise?
Symbios Medical Products raised a total of $2.05M.
Who are the investors of Symbios Medical Products?
Investors of Symbios Medical Products include Main Street Venture Fund, StepStone Angels, Hopewell Ventures and InvestIn Forum.
Who are Symbios Medical Products's competitors?
Competitors of Symbios Medical Products include MicroTransponder, OrthAlign, Flowonix Medical, Sequana Medical, Entellus Medical and 13 more.
Compare Symbios Medical Products to Competitors
USGI Medical is committed to the development of technologies that enable incisionless procedures which help patients return to normal activities and lifestyles faster compared to traditional laparoscopic and open surgery.
Interventional Spine, fka Triage Medical, is a medical device company focused on the design, development, and marketing of patented percutaneous systems to treat lower back pain. Interventional Spine's expandable cage technology provides optimal tactile feedback for the surgeon, and features a continuously adjustable design that allows the surgeon to customize the device height to the patient's anatomy. The implants are designed to maximize bone graft contact and containment, which helps promote bone growth and fusion. The company was founded in 2000 and is based in Irvine, California.
Disc Dynamics has developed the DASCORTM Disc Arthroplasty System, an innovative, minimally invasive nucleus replacement treatment for patients suffering from chronic low back pain caused by Degenerative Disc Disease (DDD).
Flowonix designs, develops, and deploys targeted drug delivery platforms whose sole purpose is to provide physicians an optimal solution for the treatment of their patients' numerous neurological disorders.
Biorthex is an orthopedic device manufacturer that develops manufactures and markets innovative spinal interbody fusion devices and instruments for the treatment of degenerative conditions of the human spine
Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.